|
In geriatric evaluation, some iadl (Katz) scale items are more predictive of efficacy and toxicity than ADL (Lawton) scale or Charlson Comorbidity Index in metastasic castration-resistant protate cancer (mCRPC) patients treated with cabazitaxel in a weekly schedule. |
|
Miguel Angel Climent Duran |
Honoraria - Astellas Oncology; Bayer; Janssen; Sanofi/Aventis |
Consulting or Advisory Role - Astellas Oncology; Bayer; Janssen; Sanofi/Aventis |
Travel, Accommodations, Expenses - Astellas Oncology; Janssen; Sanofi/Aventis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |